Sensitive immunoassays for the detection of tumor biomarkers play an important role in the early diagnosis and therapy of cancer. Using luminescent nanomaterials as labels can significantly improve immunoassay performance, especially in terms of sens...
Segmenting histological images and analyzing relevant regions are crucial for supporting pathologists in diagnosing various diseases. In prostate cancer diagnosis, Gleason grading and scoring relies on the recognition of different patterns in tissue ...
Purpose To develop and evaluate a novel deep learning-based approach for registering presurgical MR and whole-mount histopathology (WMHP) images of the prostate. Materials and Methods This retrospective study included patients who underwent prostate ...
PURPOSE: Artificial intelligence (AI) tools could improve clinical decision making or exacerbate inequities because of bias. African American (AA) men reportedly have a worse prognosis for prostate cancer (PCa) and are underrepresented in the develop...
This review examines diagnostic methods for prostate cancer, focusing on the role of digital rectal examination (DRE) alongside modern advancements like prostate-specific antigen (PSA) testing, Prostate Health Index (PHI), magnetic resonance imaging ...
Purpose To assess the effect of scanner manufacturer and scanning protocol on the performance of deep learning models to classify aggressiveness of prostate cancer (PCa) at biparametric MRI (bpMRI). Materials and Methods In this retrospective study, ...
PURPOSE: Bone metastasis is a critical complication in prostate cancer, significantly impacting patient prognosis and quality of life. This study aims to enhance bone metastasis prediction using machine learning (ML) techniques by integrating dynamic...
Journal of magnetic resonance imaging : JMRI
May 1, 2025
BACKGROUND: Artificial intelligence (AI) assistance may enhance radiologists' performance in detecting clinically significant prostate cancer (csPCa) on MRI. Further validation is needed for radiologists with different experiences.
Clinical cancer research : an official journal of the American Association for Cancer Research
Apr 14, 2025
PURPOSE: A multimodal artificial intelligence (MMAI) biomarker was developed using clinical trial data from North American men with localized prostate cancer treated with definitive radiation, using biopsy digital pathology images and key clinical in...
Studies in health technology and informatics
Apr 8, 2025
This study investigated healthcare utilization patterns prior to prostate cancer diagnoses, aiming to develop machine learning models for early prediction of cancer diagnosis. Data from the All of Us Research Program was used, focusing on adult patie...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.